HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Remers Selected Research

azonafide

3/2001Preclinical antitumor activity of the azonafide series of anthracene-based DNA intercalators.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Remers Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
03/2001
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2001
1Renal Cell Carcinoma (Grawitz Tumor)
03/2001
1Leukemia
03/2001
1Lung Neoplasms (Lung Cancer)
03/2001
1Melanoma (Melanoma, Malignant)
03/2001
1Multiple Myeloma
03/2001
1Neoplasms (Cancer)
03/2001
1Sarcoma (Soft Tissue Sarcoma)
03/2001
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
03/2001

Drug/Important Bio-Agent (IBA)

1C 39 (C39)IBA
03/2001
1anthraceneIBA
03/2001
1amonafideIBA
03/2001
1azonafideIBA
03/2001
12- (2'- (dimethylamino)ethyl)- 1,2- dihydro- 7- ethoxydibenz(de,h)isoquinoline- 1,3- dioneIBA
03/2001
1AgarIBA
03/2001
1DNA (Deoxyribonucleic Acid)IBA
03/2001
1Intercalating AgentsIBA
03/2001